Home Newsfeeds Keybanc Initiates Coverage On Pegasystems with Sector Weight Rating

Keybanc Initiates Coverage On Pegasystems with Sector Weight Rating

Keybanc analyst Thomas Blakey initiates coverage on Pegasystems (NASDAQ:PEGA) with a Sector Weight rating.

byBenzinga Newsdesk

September 13, 2022

1 minute read

Keybanc analyst Thomas Blakey initiates coverage on Pegasystems (NASDAQ:PEGA) with a Sector Weight rating.

The Future Of This Cannabis Company Is At Risk Says Co-Founder Seeking Changes To The Board Of Directors

By Vuk Zdinjak

June 12, 8:12 AM

Jesse and Joel Stanley (the “concerned shareholders”), co-founders of Charlotte’s Web Holdings, Inc.

CWBHF

Goldman Sachs Reinstates Buy on American Intl Gr, Announces $83 Price Target

By Benzinga Newsdesk

October 10, 8:28 AM

Goldman Sachs analyst Alex Scott reinstates American Intl Gr (NYSE:AIG) with a Buy and announces $83 price target.

AIG

Quantum Leap Healthcare Collaborative Announces Result Of Oral Paclitaxel In Combination With A PD-1 And Carboplatin From I-SPY2 TRIAL At ASCO

By Benzinga Newsdesk

May 1, 1:01 PM

Quantum Leap Healthcare Collaborative (Quantum Leap) and Athenex, Inc. (NASDAQ:ATNX) will present the findings of the I-SPY 2 TRIAL evaluation of Athenex's oral paclitaxel plus encequidar in combination with

ATNX

Eli Lilly Reveals Topline Data From Pivotal Study In Rare Type Of Thyroid Cancer

By Vandana Singh

August 22, 3:07 PM

Eli Lilly And Co (NYSE: LLY) released topline results from the LIBRETTO-531 study evaluating Retevmo versus the physician's choice of the multikinase inhibitors (MKIs) cabozantinib or vandetanib as an initial treatment for patients with advanced or metastatic rearranged during transfection (RET)-mutan

LLY

Keybanc Initiates Coverage On Pegasystems with Sector Weight Rating

Related Posts

The Future Of This Cannabis Company Is At Risk Says Co-Founder Seeking Changes To The Board Of Directors

Goldman Sachs Reinstates Buy on American Intl Gr, Announces $83 Price Target

Quantum Leap Healthcare Collaborative Announces Result Of Oral Paclitaxel In Combination With A PD-1 And Carboplatin From I-SPY2 TRIAL At ASCO

Eli Lilly Reveals Topline Data From Pivotal Study In Rare Type Of Thyroid Cancer